• 1
    Chapman PB, Einhorn LH, Meyers ML, et al. Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol. 1999; 17: 2745-2751.
  • 2
    Middleton MR, Grob JJ, Aaronson N, et al. Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol. 2000; 18: 158-166.
  • 3
    Atkins MB, Lotze MT, Dutcher JP, et al. High-dose recombinant interleukin-2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993. J Clin Oncol. 1999; 17: 2105-2116.
  • 4
    Barth A, Wanek LA, Morton DL. Prognostic factors in 1,521 melanoma patients with distant metastases. J Am Coll Surg. 1995; 181: 193-201.
  • 5
    Feun LG, Gutterman J, Burgess MA, et al. The natural history of resectable metastatic melanoma (Stage IVA melanoma). Cancer. 1982; 50: 1656-1663.
  • 6
    Brand CU, Ellwanger U, Stroebel W, et al. Prolonged survival of 2 years or longer for patients with disseminated melanoma. An analysis of related prognostic factors. Cancer. 1997; 79: 2345-2353.
  • 7
    McLoughlin JM, Zager JS, Sondak VK, et al. Treatment options for limited or symptomatic metastatic melanoma. Cancer Control. 2008; 15: 239-247.
  • 8
    Wong SL, Coit DG. Role of surgery in patients with stage IV melanoma. Curr Opin Oncol. 2004; 16: 155-160.
  • 9
    Martinez SR, Young SE. A rational surgical approach to the treatment of distant melanoma metastases. Cancer Treat Rev. 2008; 34: 614-620.
  • 10
    Ollila DW. Complete metastasectomy in patients with stage IV metastatic melanoma. Lancet Oncol. 2006; 1: 919-924.
  • 11
    Young SE, Martinez SR, Essner R. The role of surgery in treatment of stage IV melanoma. J Surg Oncol. 2006; 94: 344-351.
  • 12
    Wood TF, DiFronzo LA, Rose DM, et al. Does complete resection of melanoma metastatic to solid intra-abdominal organs improve survival? Ann Surg Oncol. 2001; 8: 658-662.
  • 13
    Ollila DW, Essner R, Wanek LA, et al. Surgical resection for melanoma metastatic to the gastrointestinal tract. Arch Surg. 1996; 131: 975-980.
  • 14
    Agrawal S, Yao TJ, Coit DG. Surgery for melanoma metastatic to the gastrointestinal tract. Ann Surg Oncol. 1999; 6: 336-344.
  • 15
    Ollila DW, Morton DL. Surgical resection as the treatment of choice for melanoma metastatic to the lung. Chest Surg Clin N Am. 1998; 8: 183-196.
  • 16
    Leo F, Cagini L, Rocmans P, et al. Lung metastases from melanoma: when is surgical treatment warranted? Br J Cancer. 2000; 83: 569-572.
  • 17
    Petersen RP, Hanish SI, Haney JC, et al. Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma. J Thorac Cardiovasc Surg. 2007; 133: 104-110.
  • 18
    Hsueh EC, Essner R, Foshag LJ, et al. Prolonged survival after complete resection of disseminated melanoma and active immunotherapy with a therapeutic cancer vaccine. J Clin Oncol. 2002; 20: 4549-4554.
  • 19
    Morton DL, Mozzillo N, Thompson JF, et al. An international, randomized, phase III trial of bacillus Calmette-Guerin (BCG) plus allogeneic melanoma vaccine (MCV) or placebo after complete resection of melanoma metastatic to regional or distant sites [abstract]. J Clin Oncol. 2007; 25( suppl): 474s.
  • 20
    Sondak VK, Liu PY, Warneke J, et al. Surgical resection for stage IV melanoma: A Southwest Oncology Group trial [abstract]. J Clin Oncol. 2006; 24( suppl): 457s.
  • 21
    Brookmeyer R, Crowley J. A confidence interval for the median survival time. Biometrics. 1982; 38: 29-41.
  • 22
    Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53: 457-481.
  • 23
    Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001; 19: 3635-3648.
  • 24
    Cox DR. Regression models and life tables. J R Stat Soc Ser B. 1972; 34: 187-220.
  • 25
    Korn EL, Liu PY, Lee SJ, et al. Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials. J Clin Oncol. 2008; 26: 527-534.
  • 26
    Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009; 27: 6199-6206.
  • 27
    Spitler LE, Grossbard ML, Ernstoff MS, et al. Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor. J Clin Oncol. 2000; 18: 1614-1621.
  • 28
    Viros A, Fridlyand J, Bauer J,, et al. Improving melanoma classification by integrating genetic and morphologic features. PLos Med. 2008; 5: e120.
  • 29
    Curtin JA, Fridlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005; 353: 2135-2147.